3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Basal Cell
4
Multiple Myeloma
3
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Lymphoma
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Neoplasms, Basal Cell
1
Meningioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Chondrosarcoma, Mesenchymal
1
Chondrosarcoma, Clear Cell
1
Chondrosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Specimen Handling
3
Doxorubicin
3
Biopsy
3
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Gemcitabine
2
toripalimab
1
talimogene laherparepvec
1
ribociclib
1
peposertib
1
pazopanib
1
liposomal doxorubicin
1
cabozantinib
1
abemaciclib
1
Temozolomide
1
Surgical Procedures, Operative
1
PM 01183
1
Nivolumab
1
Neoadjuvant Therapy
1
Ifosfamide
1
Everolimus
1
Docetaxel
1
ADI PEG20
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leiomyosarcoma
×
HhAntag691
×
90 days
×
Clear all
No trials found.